Skip to main content
logo
SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
11.05
+0.01 (0.09%)
At close: Aug 11, 2026, 4:00 PM EDT
11.06
+0.01 (0.06%)
After-hours: Aug 11, 2026, 7:59 PM EDT

SLS Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----17.6
Revenue Growth
-----86.84%300.00%
Cost of Revenue
----0.10.2
Gross Profit
----0.97.4
Selling, General & Admin
14.8712.2512.4213.8612.5811.32
Research & Development
20.3516.0219.124.0120.2715.67
Other Operating Expenses
----105.7
Total Operating Expenses
35.2228.2731.5137.8742.8532.69
Operating Income
-35.22-28.27-31.51-37.87-41.95-25.29
Interest Income
2.761.410.630.530.320.01
Other Non-Operating Income (Expense)
---00.334.35
Total Non-Operating Income (Expense)
2.761.410.630.530.654.36
Pretax Income
-32.46-26.86-30.88-37.34-41.3-20.94
Provision for Income Taxes
------0.24
Net Income
-32.46-26.86-30.88-37.34-41.3-20.7
Net Income to Common
-32.46-26.86-30.88-37.34-41.3-20.7
Net Income Growth
------
Shares Outstanding (Basic)
15310961281915
Shares Outstanding (Diluted)
15310961281915
Shares Change
86.06%78.18%120.33%43.21%25.29%94.07%
EPS (Basic)
-0.21-0.25-0.50-1.34-2.13-1.34
EPS (Diluted)
-0.21-0.25-0.50-1.34-2.13-1.34
EPS Growth
------
Free Cash Flow
-28.42-28.39-35.4-31.41-23.81-26.02
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.19-0.26-0.58-1.13-1.23-1.68
Gross Margin
----90.00%97.37%
Operating Margin
-----4195.00%-332.82%
Profit Margin
-----4130.10%-272.36%
FCF Margin
-----2380.90%-342.38%
EBITDA
-35.22-28.27-31.51-37.87-41.95-25.29
EBIT
-35.22-28.27-31.51-37.87-41.95-25.29
EBIT Margin
-----4195.00%-332.82%
Effective Tax Rate
-0.00%0.00%0.00%0.00%1.13%
SEC Filings: 10-K · 10-Q